NCT05978466 MANAGE-AF Registry -MANAGEment of Atrial Fibrillation Outcomes Registry (MANAGE-AF)
| NCT ID | NCT05978466 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CorVita Science Foundation |
| Condition | Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2017-12-22 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2017-12-22 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research is to learn more about the normal care of patients with a new or pre-existing diagnosis of atrial fibrillation (AF). These abnormal and irregular heartbeats place patients at increased risk of developing clots in their bloodstream that could potentially lead to stroke. Normal care is designed to help prevent this from happening and to lessen or eliminate the symptoms patients may have. There are many different types of AF as well as numerous ways in which a variety of patients are treated. The investigators are interested in gathering more information to better keep track of patient treatment patterns (trends) that may differ from physician to physician, hospital to hospital, medication to medication, patient to patient and if necessary, procedure to procedure.
Eligibility Criteria
Inclusion Criteria: 1. Diagnosis of valvular or non valvular atrial fibrillation 2. ECG documented atrial fibrillation A. 12 lead B. Rhythm strip C. Event monitor D. Holter Monitor E. Implantable loop recorder Exclusion Criteria: 1. Age below 18 years. 2. Clinical evidence that death within 6 months is possible 3. Inability to consent to the research or sign a consent form 4. Inability to follow up at the research clinic at least annually for continuity of AF care and management
Contact & Investigator
Martin C Burke, DO
PRINCIPAL INVESTIGATOR
Chief Scientific Officer
Frequently Asked Questions
Who can join the NCT05978466 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05978466 currently recruiting?
Yes, NCT05978466 is actively recruiting participants. Contact the research team at eddie@corvitahealth.org for enrollment information.
Where is the NCT05978466 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT05978466 clinical trial?
NCT05978466 is sponsored by CorVita Science Foundation. The principal investigator is Martin C Burke, DO at Chief Scientific Officer. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.